716 related articles for article (PubMed ID: 24568455)
21. Docetaxel-loaded polylactic acid-co-glycolic acid nanoparticles: formulation, physicochemical characterization and cytotoxicity studies.
Pradhan R; Poudel BK; Ramasamy T; Choi HG; Yong CS; Kim JO
J Nanosci Nanotechnol; 2013 Aug; 13(8):5948-56. PubMed ID: 23882865
[TBL] [Abstract][Full Text] [Related]
22. Conjugation of cell-penetrating peptides with poly(lactic-co-glycolic acid)-polyethylene glycol nanoparticles improves ocular drug delivery.
Vasconcelos A; Vega E; Pérez Y; Gómara MJ; García ML; Haro I
Int J Nanomedicine; 2015; 10():609-31. PubMed ID: 25670897
[TBL] [Abstract][Full Text] [Related]
23. Development of poly(lactic-co-glycolic) acid nanoparticles-embedded hyaluronic acid-ceramide-based nanostructure for tumor-targeted drug delivery.
Park JH; Lee JY; Termsarasab U; Yoon IS; Ko SH; Shim JS; Cho HJ; Kim DD
Int J Pharm; 2014 Oct; 473(1-2):426-33. PubMed ID: 25079433
[TBL] [Abstract][Full Text] [Related]
24. Potential use of polymeric nanoparticles for drug delivery across the blood-brain barrier.
Tosi G; Bortot B; Ruozi B; Dolcetta D; Vandelli MA; Forni F; Severini GM
Curr Med Chem; 2013; 20(17):2212-25. PubMed ID: 23458620
[TBL] [Abstract][Full Text] [Related]
25. Biodegradable nanoparticles sequentially decorated with Polyethyleneimine and Hyaluronan for the targeted delivery of docetaxel to airway cancer cells.
Maiolino S; Russo A; Pagliara V; Conte C; Ungaro F; Russo G; Quaglia F
J Nanobiotechnology; 2015 Apr; 13():29. PubMed ID: 25888948
[TBL] [Abstract][Full Text] [Related]
26. Tetracycline-grafted PLGA nanoparticles as bone-targeting drug delivery system.
Wang H; Liu J; Tao S; Chai G; Wang J; Hu FQ; Yuan H
Int J Nanomedicine; 2015; 10():5671-85. PubMed ID: 26388691
[TBL] [Abstract][Full Text] [Related]
27. Biomedical applications of PLGA nanoparticles in nanomedicine: advances in drug delivery systems and cancer therapy.
Narmani A; Jahedi R; Bakhshian-Dehkordi E; Ganji S; Nemati M; Ghahramani-Asl R; Moloudi K; Hosseini SM; Bagheri H; Kesharwani P; Khani A; Farhood B; Sahebkar A
Expert Opin Drug Deliv; 2023; 20(7):937-954. PubMed ID: 37294853
[TBL] [Abstract][Full Text] [Related]
28. Biocompatible amphiphilic pentablock copolymeric nanoparticles for anti-cancer drug delivery.
Byagari K; Shanavas A; Rengan AK; Kundu GC; Srivastava R
J Biomed Nanotechnol; 2014 Jan; 10(1):109-19. PubMed ID: 24724503
[TBL] [Abstract][Full Text] [Related]
29. Micelle-templated, poly(lactic-
Nabar GM; Mahajan KD; Calhoun MA; Duong AD; Souva MS; Xu J; Czeisler C; Puduvalli VK; Otero JJ; Wyslouzil BE; Winter JO
Int J Nanomedicine; 2018; 13():351-366. PubMed ID: 29391794
[TBL] [Abstract][Full Text] [Related]
30. Self-assembled hybrid nanoparticles for targeted co-delivery of two drugs into cancer cells.
Huang F; You M; Chen T; Zhu G; Liang H; Tan W
Chem Commun (Camb); 2014 Mar; 50(23):3103-5. PubMed ID: 24516863
[TBL] [Abstract][Full Text] [Related]
31. Engineered PLGA nanoparticles: an emerging delivery tool in cancer therapeutics.
Jain AK; Das M; Swarnakar NK; Jain S
Crit Rev Ther Drug Carrier Syst; 2011; 28(1):1-45. PubMed ID: 21395514
[TBL] [Abstract][Full Text] [Related]
32. PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect.
Acharya S; Sahoo SK
Adv Drug Deliv Rev; 2011 Mar; 63(3):170-83. PubMed ID: 20965219
[TBL] [Abstract][Full Text] [Related]
33. Surface modification of PLGA nanoparticles via human serum albumin conjugation for controlled delivery of docetaxel.
Manoochehri S; Darvishi B; Kamalinia G; Amini M; Fallah M; Ostad SN; Atyabi F; Dinarvand R
Daru; 2013 Jul; 21(1):58. PubMed ID: 23866721
[TBL] [Abstract][Full Text] [Related]
34. Poly((D,L)lactic-glycolic)acid-star glucose nanoparticles for glucose transporter and hypoglycemia-mediated tumor targeting.
Park JH; Cho HJ; Kim DD
Int J Nanomedicine; 2017; 12():7453-7467. PubMed ID: 29066894
[TBL] [Abstract][Full Text] [Related]
35. [Rapamycin-loaded poly (lactic-co-glycolic) acid nanoparticles for intraarterial local drug delivery: preparation, characterization, and in vitro/in vivo release].
Miao LF; Yang J; Huang CL; Song CX; Zeng YJ; Chen LF; Zhu WL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Aug; 30(4):491-7. PubMed ID: 18795627
[TBL] [Abstract][Full Text] [Related]
36. PLGA Microparticles Entrapping Chitosan-Based Nanoparticles for the Ocular Delivery of Ranibizumab.
Elsaid N; Jackson TL; Elsaid Z; Alqathama A; Somavarapu S
Mol Pharm; 2016 Sep; 13(9):2923-40. PubMed ID: 27286558
[TBL] [Abstract][Full Text] [Related]
37. Mechanisms of chitosan-coated poly(lactic-co-glycolic acid) nanoparticles for improving oral absorption of 7-ethyl-10-hydroxycamptothecin.
Guo M; Rong WT; Hou J; Wang DF; Lu Y; Wang Y; Yu SQ; Xu Q
Nanotechnology; 2013 Jun; 24(24):245101. PubMed ID: 23702815
[TBL] [Abstract][Full Text] [Related]
38. Hybrid poly(lactic-co-glycolic acid) nanoparticles: design and delivery prospectives.
Pandita D; Kumar S; Lather V
Drug Discov Today; 2015 Jan; 20(1):95-104. PubMed ID: 25277320
[TBL] [Abstract][Full Text] [Related]
39. Electrohydrodynamic fabrication of core-shell PLGA nanoparticles with controlled release of cisplatin for enhanced cancer treatment.
Reardon PJ; Parhizkar M; Harker AH; Browning RJ; Vassileva V; Stride E; Pedley RB; Edirisinghe M; Knowles JC
Int J Nanomedicine; 2017; 12():3913-3926. PubMed ID: 28579777
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and in vitro studies of PLGA-DTX nanoconjugate as potential drug delivery vehicle for oral cancer.
Gupta P; Singh M; Kumar R; Belz J; Shanker R; Dwivedi PD; Sridhar S; Singh SP
Int J Nanomedicine; 2018; 13(T-NANO 2014 Abstracts):67-69. PubMed ID: 29593398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
